Page last updated: 2024-08-07 19:36:57

BZLF2

[no definition available]

Synonyms

Research

Bioassay Publications (0)

TimeframeStudies on this Protein(%)All Drugs %
pre-19900 (0)18.7374
1990's0 (0)18.2507
2000's0 (0)29.6817
2010's0 (0)24.3611
2020's0 (0)2.80

Compounds (47)

Drugs with Inhibition Measurements

DrugTaxonomyMeasurementAverage (mM)Bioassay(s)Publication(s)
hexachloropheneHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC505.970010
disperse red 9Human herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC502.800010
1-amino-4-hydroxyanthraquinoneHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC503.100010
2,4-dihydroxybenzophenoneHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC500.420010
lysergolHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5012.380010
s-2678Human herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC501.320010
diacetylfluoresceinHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC500.420010
2,2'-((3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)diimino)bis-benzoic acidHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
coumarin 153Human herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC500.420010
methyl fluorone blackHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC501.000010
9-hydroxyphenylfluoronHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC505.290010
ergocornineHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC503.640010
2-butyl-6-(butylamino)-1h-benzo(de)isoquinoline-1,3(2h)-dioneHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC500.420010
paxillineHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC502.030010
epiberberineHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC500.420010
2,3-diaminophenazineHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC500.420010
6-amino-2-methyl-8-phenyl-1,6,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrileHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC504.530010
1-[3-[1-cyano-2-oxo-2-[(phenylmethyl)amino]ethyl]-2-quinoxalinyl]-3-piperidinecarboxylic acid ethyl esterHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC508.820010
2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid hexyl esterHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5014.550010
4-tert-butyl-N-(1,4-dioxo-2,3-dihydrophthalazin-5-yl)benzamideHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC505.970010
2-[(1-ethyl-2,5-dimethyl-3-pyrrolyl)methylidene]indene-1,3-dioneHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5016.230010
4,5-dimethylcyclopenta[c]quinolizine-1,2-dicarboxylic acid dimethyl esterHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC503.610010
1,4,8-trimethyl-12-quinolino[2,3-b]quinolinamineHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC500.920010
3-amino-2-(4-methoxyphenyl)-7-nitro-1-oxo-4-isoquinolinecarbonitrileHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
1-(3,4-dichlorophenyl)-3-(5-pyridin-4-yl-1,3,4-thiadiazol-2-yl)ureaHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC502.540010
1-[2,3-bis(2-furanyl)-6-quinoxalinyl]-3-[4-(4-morpholinyl)phenyl]thioureaHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC503.860010
4-[[4-(2,3-dimethylphenyl)-1-piperazinyl]methyl]-2,6-dimethoxyphenolHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
9-methoxy-6-[(4-methoxyphenyl)methyl]indolo[3,2-b]quinoxalineHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC503.270010
[4-chloro-6-(propan-2-ylamino)-1,3,5-triazin-2-yl]-[(1,1,3-trioxo-1,2-benzothiazol-2-yl)methyl]cyanamideHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
2-[2-[[2-[(3-carbamoyl-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)amino]-2-oxoethyl]thio]-4-thiazolyl]acetic acid ethyl esterHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
2-(2-cyanophenoxy)acetic acid [2-(2,5-dimethyl-1-prop-2-enyl-3-pyrrolyl)-2-oxoethyl] esterHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
4-[3-(2,5-dimethyl-1-pyrrolyl)-4-(1-pyrrolidinyl)phenyl]sulfonylmorpholineHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
2-[[4-amino-5-[4-(difluoromethoxy)phenyl]-1,2,4-triazol-3-yl]thio]-N-[(2-furanylmethylamino)-oxomethyl]acetamideHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5031.140010
2-amino-4-(4,5-dimethoxy-2-nitrophenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbonitrileHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC506.610010
N-[4-methyl-5-[2-(3-nitroanilino)-4-thiazolyl]-2-thiazolyl]acetamideHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
LSM-16248Human herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC502.730010
4-[[3-[(4-chlorophenyl)sulfonylamino]-2-quinoxalinyl]amino]-1-piperidinecarboxylic acid ethyl esterHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
7-[[[1-(3-methylphenyl)-2-benzimidazolyl]thio]methyl]-5-thiazolo[3,2-a]pyrimidinoneHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC502.790010
2-benzoyl-N-(6-methoxy-3-pyridinyl)-3,4-dihydro-1H-isoquinoline-3-carboxamideHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC508.480010
N-[(2-hydroxy-1-naphthalenyl)-(4-methylphenyl)methyl]cyclohexanecarboxamideHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
N-(2-furanylmethyl)-1-[2-(2-hydroxyethoxy)ethyl]-2-imino-10-methyl-5-oxo-3-dipyrido[3,4-c-1',2'-f]pyrimidinecarboxamideHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC503.610010
N-[(4-methylphenyl)methyl]-4-(1-pyrrolyl)benzamideHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
LSM-16826Human herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC506.050010
methysergide maleateHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
3-(dimethylamino)benzoic acid (7-hydroxy-2-oxo-1-benzopyran-4-yl)methyl esterHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC5054.000010
LSM-6455Human herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC508.520010
N-[3-[(1,5-dimethyl-3-oxo-2-phenyl-4-pyrazolyl)amino]-1-isoindolylidene]-2-thiophenecarboxamideHuman herpesvirus 4 type 2 (Epstein-Barr virus type 2)IC503.190010